Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 123,598 shares of IOVA stock, worth $286,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,598
Previous 32,399
281.49%
Holding current value
$286,747
Previous $107,000
98.13%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IOVA
# of Institutions
292Shares Held
233MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.2 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.4 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $366M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...